Published in Gene Therapy Weekly, July 21st, 1997
In March 1996, HGS licensed F. Hoffman-La Roche, Basel, Switzerland, and Hoffmann-La Roche Inc. (Roche), Nutley, New Jersey, the right to use the S. pneumoniae sequence information to identify potential new anti-infectives and antibiotics in return for an upfront payment, a milestone related to sequencing, and royalties on the sale of certain products.
S. pneumoniae is the most common cause of bacterial pneumonia. Although...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.